178 related articles for article (PubMed ID: 27110447)
1. Risk of pneumonia associated with zero-degree head positioning in acute ischemic stroke patients treated with intravenous tissue plasminogen activator.
Palazzo P; Brooks A; James D; Moore R; Alexandrov AV; Alexandrov AW
Brain Behav; 2016 Feb; 6(2):e00425. PubMed ID: 27110447
[TBL] [Abstract][Full Text] [Related]
2. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
[TBL] [Abstract][Full Text] [Related]
3. Thrombolysis in acute ischemic stroke is associated with lower long-term hospital bed day use: A nationwide propensity score-matched follow-up study.
Terkelsen T; Schmitz ML; Simonsen CZ; Hundborg HH; Christensen HK; Gyllenborg J; Sandal BF; Iversen HK; Madsen C; Rasmussen MJ; Vestergaard K; Andersen G; Johnsen SP
Int J Stroke; 2016 Oct; 11(8):910-916. PubMed ID: 27312677
[TBL] [Abstract][Full Text] [Related]
4. The effect of metabolic syndrome and obesity on outcomes of acute ischemic stroke patients treated with systemic thrombolysis.
Bas DF; Ozdemir AO
J Neurol Sci; 2017 Dec; 383():1-4. PubMed ID: 29246591
[TBL] [Abstract][Full Text] [Related]
5. Should we exclude acute stroke patients with previous intracerebral hemorrhage from receiving intravenous thrombolysis?
Lee SH; Kim BJ; Han MK; Park TH; Lee KB; Lee BC; Yu KH; Oh MS; Cha JK; Kim DH; Nah HW; Lee J; Lee SJ; Ko Y; Kim JG; Park JM; Kang K; Cho YJ; Hong KS; Choi JC; Kim JT; Choi K; Kim DE; Ryu WS; Kim WJ; Shin DI; Yeo M; Lee J; Lee JS; Gorelick PB; Bae HJ
Int J Stroke; 2016 Oct; 11(7):783-90. PubMed ID: 27312681
[TBL] [Abstract][Full Text] [Related]
6. Acute stroke management in the elderly.
Zeevi N; Chhabra J; Silverman IE; Lee NS; McCullough LD
Cerebrovasc Dis; 2007; 23(4):304-8. PubMed ID: 17199089
[TBL] [Abstract][Full Text] [Related]
7. Cluster-Randomized, Crossover Trial of Head Positioning in Acute Stroke.
Anderson CS; Arima H; Lavados P; Billot L; Hackett ML; Olavarría VV; Muñoz Venturelli P; Brunser A; Peng B; Cui L; Song L; Rogers K; Middleton S; Lim JY; Forshaw D; Lightbody CE; Woodward M; Pontes-Neto O; De Silva HA; Lin RT; Lee TH; Pandian JD; Mead GE; Robinson T; Watkins C;
N Engl J Med; 2017 Jun; 376(25):2437-2447. PubMed ID: 28636854
[TBL] [Abstract][Full Text] [Related]
8. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
9. Tissue plasminogen activator overdose in acute ischemic stroke patients linked to poorer functional outcomes.
Sahlas DJ; Gould L; Swartz RH; Mohammed N; McNicoll-Whiteman R; Naufal F; Oczkowski W
J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):155-9. PubMed ID: 23375748
[TBL] [Abstract][Full Text] [Related]
10. Predictors of systemic inflammatory response syndrome in ischemic stroke undergoing systemic thrombolysis with intravenous tissue plasminogen activator.
Boehme AK; Kapoor N; Albright KC; Lyerly MJ; Rawal PV; Bavarsad Shahripour R; Alvi M; Houston JT; Sisson A; Beasley TM; Alexandrov AW; Alexandrov AV; Miller DW
J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):e271-6. PubMed ID: 24424334
[TBL] [Abstract][Full Text] [Related]
11. Solitaire™ with the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke (SWIFT PRIME) trial: protocol for a randomized, controlled, multicenter study comparing the Solitaire revascularization device with IV tPA with IV tPA alone in acute ischemic stroke.
Saver JL; Goyal M; Bonafe A; Diener HC; Levy EI; Pereira VM; Albers GW; Cognard C; Cohen DJ; Hacke W; Jansen O; Jovin TG; Mattle HP; Nogueira RG; Siddiqui AH; Yavagal DR; Devlin TG; Lopes DK; Reddy V; du Mesnil de Rochemont R; Jahan R;
Int J Stroke; 2015 Apr; 10(3):439-48. PubMed ID: 25777831
[TBL] [Abstract][Full Text] [Related]
12. Intravenous tissue-type plasminogen activator therapy for ischemic stroke: Houston experience 1996 to 2000.
Grotta JC; Burgin WS; El-Mitwalli A; Long M; Campbell M; Morgenstern LB; Malkoff M; Alexandrov AV
Arch Neurol; 2001 Dec; 58(12):2009-13. PubMed ID: 11735774
[TBL] [Abstract][Full Text] [Related]
13. The association of blood pressure and collateral circulation in hyperacute ischemic stroke patients treated with intravenous thrombolysis.
Rusanen H; Saarinen JT; Sillanpää N
Cerebrovasc Dis; 2015; 39(2):130-7. PubMed ID: 25660943
[TBL] [Abstract][Full Text] [Related]
14. Emergency department shift change is associated with pneumonia in patients with acute ischemic stroke.
Jones EM; Albright KC; Fossati-Bellani M; Siegler JE; Martin-Schild S
Stroke; 2011 Nov; 42(11):3226-30. PubMed ID: 21903956
[TBL] [Abstract][Full Text] [Related]
15. The correlation between admission blood glucose and intravenous rt-PA-induced arterial recanalization in acute ischemic stroke: a multi-centre TCD study.
Saqqur M; Shuaib A; Alexandrov AV; Sebastian J; Khan K; Uchino K
Int J Stroke; 2015 Oct; 10(7):1087-92. PubMed ID: 26332252
[TBL] [Abstract][Full Text] [Related]
16. Does modern ischemic stroke therapy in a large community-based dedicated stroke center improve clinical outcomes? A two-year retrospective study.
Berlet MH; Stambo GW; Kelley M; Van Epps K; Woeste T; Steffen D
J Stroke Cerebrovasc Dis; 2014; 23(5):869-78. PubMed ID: 24011839
[TBL] [Abstract][Full Text] [Related]
17. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
[TBL] [Abstract][Full Text] [Related]
18. Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK.
Walters MR; Muir KW; Harbison J; Lees KR; Ford GA
Cerebrovasc Dis; 2005; 20(6):438-42. PubMed ID: 16230848
[TBL] [Abstract][Full Text] [Related]
19. Influence of antiplatelet pre-treatment on the risk of intracranial haemorrhage in acute ischaemic stroke after intravenous thrombolysis.
Dorado L; Millán M; de la Ossa NP; Guerrero C; Gomis M; López-Cancio E; Ricciardi AC; Dávalos A
Eur J Neurol; 2010 Feb; 17(2):301-6. PubMed ID: 19912320
[TBL] [Abstract][Full Text] [Related]
20. Use of Intravenous Thrombolytic Therapy in Acute Ischemic Stroke Patients: Evaluation of Clinical Outcomes.
Zhang PL; Wang YX; Chen Y; Zhang CH; Li CH; Dong Z; Yin H; Zhang FF; Wang JH
Cell Biochem Biophys; 2015 May; 72(1):11-7. PubMed ID: 25552251
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
